"The Urogynecology Center located in Overland Park, KS offers advanced medical care to women in the greater Kansas City area. Our clinic provides the highest level of care possible for women with incontinence, pelvic pain and/or pelvic organ prolapse and more. Our team is highly-trained with minimally invasive surgeries to improve care for women. This technique minimizes pain for the patient, reduces time spent in the hospital, allows for fewer complications and decreases the risk of wound infections."

During the past decade, The Urogynecology Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "The Urogynecology Center" are "Interstitial Cystitis" (2 trials), "Bladder Diseases" (1 trials), "Bladder Pain Syndrome" (1 trials) and "Pelvic Pain" (1 trials). Many other conditions were trialed in "The Urogynecology Center" in a lesser frequency.

Most popular intervention types in "The Urogynecology Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Alkalinized Lidocaine-Heparin" (1 trials), "Heparin" (1 trials), "Lidocaine" (1 trials), "Placebo" (1 trials) and "URG101" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Urogynecology Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "The Urogynecology Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in The Urogynecology Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The Urogynecology Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

The Urogynecology Center has several departments that took part in Clinical trials: "Kansas City Gastroenterology and Hepatology" - 25 trials, "Kansas City Internal Medicine" - 4 trials